Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$202.68M-3.1%-$196.54M-2.2%-$192.33M-5.0%-$183.1M-8.5%-$168.73M+35.3%
$77.06M+15.3%$66.82M+15.0%$58.11M+15.5%$50.3M+12.3%$44.78M+12.8%
-$119.51M-3.3%-$115.68M-6.0%-$109.13M-1.3%-$107.72M+5.1%-$113.49M+0.3%
$19.59M-1.6%$19.92M+8.7%$18.33M+13.9%$16.09M+9.2%$14.73M+14.2%
$219.5M+14.8%
-$45.9M-24.5%-$36.85M-873%$4.77M+118%-$26.02M-149%$52.67M+80.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Rhythm Pharmaceuticals, Inc. generate?
Rhythm Pharmaceuticals, Inc. (RYTM) generated -$119.5M in operating cash flow over the trailing twelve months.
Where does Rhythm Pharmaceuticals, Inc.'s cash flow data come from?
Every line is extracted from Rhythm Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.